{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T04:15:23Z","timestamp":1750306523384,"version":"3.41.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002756"],"award-info":[{"award-number":["82002756"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-025-08025-3","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T16:06:39Z","timestamp":1745510799000},"page":"273-286","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Distinct endometriosis involvement confers divergent oncologic outcomes in ovarian clear cell carcinoma"],"prefix":"10.1007","volume":"312","author":[{"given":"Jie","family":"Deng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4515-3639","authenticated-orcid":false,"given":"Tianjin","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"issue":"511\u2013519","key":"8025_CR1","doi-asserted-by":"publisher","first-page":"20120720","DOI":"10.1016\/j.fertnstert.2012.06.029","volume":"98","author":"RO Burney","year":"2012","unstructured":"Burney RO, Giudice LC (2012) Pathogenesis and pathophysiology of endometriosis. Fertil Steril 98(511\u2013519):20120720. https:\/\/doi.org\/10.1016\/j.fertnstert.2012.06.029","journal-title":"Fertil Steril"},{"issue":"500\u2013516","key":"8025_CR2","doi-asserted-by":"publisher","first-page":"20150311","DOI":"10.1093\/humupd\/dmv013","volume":"21","author":"M Kvaskoff","year":"2015","unstructured":"Kvaskoff M, Mu F, Terry KL et al (2015) Endometriosis: a high-risk population for major chronic diseases? Hum Reprod Update 21(500\u2013516):20150311. https:\/\/doi.org\/10.1093\/humupd\/dmv013","journal-title":"Hum Reprod Update"},{"issue":"599\u2013610","key":"8025_CR3","doi-asserted-by":"publisher","first-page":"20231205","DOI":"10.1007\/s00404-023-07292-2","volume":"309","author":"T Wischmann","year":"2024","unstructured":"Wischmann T, Ditzen B (2024) Endometriosis: patient-doctor communication and psychological counselling. Arch Gynecol Obstet 309(599\u2013610):20231205. https:\/\/doi.org\/10.1007\/s00404-023-07292-2","journal-title":"Arch Gynecol Obstet"},{"issue":"385\u2013394","key":"8025_CR4","doi-asserted-by":"publisher","first-page":"20120222","DOI":"10.1016\/s1470-2045(11)70404-1","volume":"13","author":"CL Pearce","year":"2012","unstructured":"Pearce CL, Templeman C, Rossing MA et al (2012) Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol 13(385\u2013394):20120222. https:\/\/doi.org\/10.1016\/s1470-2045(11)70404-1","journal-title":"Lancet Oncol"},{"key":"8025_CR5","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1634\/theoncologist.11-10-1089","volume":"11","author":"D Pectasides","year":"2006","unstructured":"Pectasides D, Pectasides E, Psyrri A et al (2006) Treatment issues in clear cell carcinoma of the ovary: a different entity? Oncologist 11:1089\u20131094. https:\/\/doi.org\/10.1634\/theoncologist.11-10-1089","journal-title":"Oncologist"},{"issue":"589\u2013596","key":"8025_CR6","doi-asserted-by":"publisher","first-page":"20190321","DOI":"10.1016\/j.ygyno.2019.03.243","volume":"153","author":"H Machida","year":"2019","unstructured":"Machida H, Matsuo K, Yamagami W et al (2019) Trends and characteristics of epithelial ovarian cancer in Japan between 2002 and 2015: A JSGO-JSOG joint study. Gynecol Oncol 153(589\u2013596):20190321. https:\/\/doi.org\/10.1016\/j.ygyno.2019.03.243","journal-title":"Gynecol Oncol"},{"key":"8025_CR7","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1002\/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5","volume":"88","author":"T Sugiyama","year":"2000","unstructured":"Sugiyama T, Kamura T, Kigawa J et al (2000) Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Cancer 88:2584\u20132589","journal-title":"Cancer"},{"key":"8025_CR8","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1097\/igc.0000000000000178","volume":"24","author":"K Suzuki","year":"2014","unstructured":"Suzuki K, Takakura S, Saito M et al (2014) Impact of surgical staging in stage I clear cell adenocarcinoma of the ovary. Int J Gynecol Cancer 24:1181\u20131189. https:\/\/doi.org\/10.1097\/igc.0000000000000178","journal-title":"Int J Gynecol Cancer"},{"key":"8025_CR9","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1006\/gyno.2000.5765","volume":"77","author":"S Ogawa","year":"2000","unstructured":"Ogawa S, Kaku T, Amada S et al (2000) Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study. Gynecol Oncol 77:298\u2013304. https:\/\/doi.org\/10.1006\/gyno.2000.5765","journal-title":"Gynecol Oncol"},{"key":"8025_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/igc.0000000000001136","volume":"28","author":"JY Park","year":"2018","unstructured":"Park JY, Kim DY, Suh DS et al (2018) Significance of ovarian endometriosis on the prognosis of ovarian clear cell carcinoma. Int J Gynecol Cancer 28:11\u201318. https:\/\/doi.org\/10.1097\/igc.0000000000001136","journal-title":"Int J Gynecol Cancer"},{"issue":"526\u2013531","key":"8025_CR11","doi-asserted-by":"publisher","first-page":"20161013","DOI":"10.1016\/j.ygyno.2016.10.009","volume":"143","author":"H Bai","year":"2016","unstructured":"Bai H, Cao D, Yuan F et al (2016) Prognostic value of endometriosis in patients with stage I ovarian clear cell carcinoma: experiences at three academic institutions. Gynecol Oncol 143(526\u2013531):20161013. https:\/\/doi.org\/10.1016\/j.ygyno.2016.10.009","journal-title":"Gynecol Oncol"},{"issue":"336\u2013344","key":"8025_CR12","doi-asserted-by":"publisher","first-page":"20080718","DOI":"10.1016\/j.ygyno.2008.05.025","volume":"110","author":"JP Orezzoli","year":"2008","unstructured":"Orezzoli JP, Russell AH, Oliva E et al (2008) Prognostic implication of endometriosis in clear cell carcinoma of the ovary. Gynecol Oncol 110(336\u2013344):20080718. https:\/\/doi.org\/10.1016\/j.ygyno.2008.05.025","journal-title":"Gynecol Oncol"},{"issue":"211\u2013213","key":"8025_CR13","doi-asserted-by":"publisher","first-page":"20130709","DOI":"10.1016\/j.ejogrb.2013.06.001","volume":"170","author":"G Boyraz","year":"2013","unstructured":"Boyraz G, Selcuk I, Yaz\u0131c\u0131o\u011flu A et al (2013) Ovarian carcinoma associated with endometriosis. Eur J Obstet Gynecol Reprod Biol 170(211\u2013213):20130709. https:\/\/doi.org\/10.1016\/j.ejogrb.2013.06.001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"413","key":"8025_CR14","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ajog.2012.12.004","volume":"208","author":"S Wang","year":"2013","unstructured":"Wang S, Qiu L, Lang JH et al (2013) Clinical analysis of ovarian epithelial carcinoma with coexisting pelvic endometriosis. Am J Obstet Gynecol 208(413):411\u2013415. https:\/\/doi.org\/10.1016\/j.ajog.2012.12.004","journal-title":"Am J Obstet Gynecol"},{"issue":"403\u2013407","key":"8025_CR15","doi-asserted-by":"publisher","first-page":"20120515","DOI":"10.1016\/j.ygyno.2012.05.007","volume":"126","author":"G Mangili","year":"2012","unstructured":"Mangili G, Bergamini A, Taccagni G et al (2012) Unraveling the two entities of endometrioid ovarian cancer: a single center clinical experience. Gynecol Oncol 126(403\u2013407):20120515. https:\/\/doi.org\/10.1016\/j.ygyno.2012.05.007","journal-title":"Gynecol Oncol"},{"key":"8025_CR16","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/IGC.0b013e31827aa0bb","volume":"23","author":"S Noli","year":"2013","unstructured":"Noli S, Cipriani S, Scarfone G et al (2013) Long term survival of ovarian endometriosis associated clear cell and endometrioid ovarian cancers. Int J Gynecol Cancer 23:244\u2013248. https:\/\/doi.org\/10.1097\/IGC.0b013e31827aa0bb","journal-title":"Int J Gynecol Cancer"},{"key":"8025_CR17","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1097\/PAS.0b013e31824b6eed","volume":"36","author":"J Cuff","year":"2012","unstructured":"Cuff J, Longacre TA (2012) Endometriosis does not confer improved prognosis in ovarian carcinoma of uniform cell type. Am J Surg Pathol 36:688\u2013695. https:\/\/doi.org\/10.1097\/PAS.0b013e31824b6eed","journal-title":"Am J Surg Pathol"},{"key":"8025_CR18","first-page":"3445","volume":"36","author":"VE Bounous","year":"2016","unstructured":"Bounous VE, Ferrero A, Fuso L et al (2016) Endometriosis-associated ovarian cancer: a distinct clinical entity? Anticancer Res 36:3445\u20133449","journal-title":"Anticancer Res"},{"issue":"63","key":"8025_CR19","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1016\/j.ajog.2010.08.017","volume":"204","author":"S Kumar","year":"2011","unstructured":"Kumar S, Munkarah A, Arabi H et al (2011) Prognostic analysis of ovarian cancer associated with endometriosis. Am J Obstet Gynecol 204(63):e61-67. https:\/\/doi.org\/10.1016\/j.ajog.2010.08.017","journal-title":"Am J Obstet Gynecol"},{"key":"8025_CR20","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1016\/s0002-9440(10)63605-x","volume":"163","author":"A Tsuchiya","year":"2003","unstructured":"Tsuchiya A, Sakamoto M, Yasuda J et al (2003) Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma. Am J Pathol 163:2503\u20132512. https:\/\/doi.org\/10.1016\/s0002-9440(10)63605-x","journal-title":"Am J Pathol"},{"key":"8025_CR21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/PAS.0b013e3181ff400e","volume":"35","author":"D DeLair","year":"2011","unstructured":"DeLair D, Oliva E, K\u00f6bel M et al (2011) Morphologic spectrum of immunohistochemically characterized clear cell carcinoma of the ovary: a study of 155 cases. Am J Surg Pathol 35:36\u201344. https:\/\/doi.org\/10.1097\/PAS.0b013e3181ff400e","journal-title":"Am J Surg Pathol"},{"issue":"39\u201345","key":"8025_CR22","doi-asserted-by":"publisher","first-page":"20120123","DOI":"10.1055\/s-0031-1299596","volume":"30","author":"SE Bulun","year":"2012","unstructured":"Bulun SE, Monsavais D, Pavone ME et al (2012) Role of estrogen receptor-\u03b2 in endometriosis. Semin Reprod Med 30(39\u201345):20120123. https:\/\/doi.org\/10.1055\/s-0031-1299596","journal-title":"Semin Reprod Med"},{"key":"8025_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/archsurg.1925.01120100007001","volume":"10","author":"JA Sampson","year":"1925","unstructured":"Sampson JA (1925) Endometrial carcinoma of the ovary, arising in endometrial tissue in that organ. Arch Surg 10:1\u201372. https:\/\/doi.org\/10.1001\/archsurg.1925.01120100007001","journal-title":"Arch Surg"},{"key":"8025_CR24","first-page":"283","volume":"2","author":"RB Scott","year":"1953","unstructured":"Scott RB (1953) Malignant changes in endometriosis. Obstet Gynecol 2:283\u2013289","journal-title":"Obstet Gynecol"},{"issue":"177\u2013183","key":"8025_CR25","doi-asserted-by":"publisher","first-page":"20190529","DOI":"10.1002\/ijgo.12861","volume":"146","author":"UC Ju","year":"2019","unstructured":"Ju UC, Kang WD, Kim SM (2019) The effect of concurrent endometriosis on the prognosis of women with ovarian clear cell or endometrioid carcinoma. Int J Gynaecol Obstet 146(177\u2013183):20190529. https:\/\/doi.org\/10.1002\/ijgo.12861","journal-title":"Int J Gynaecol Obstet"},{"issue":"225\u2013228","key":"8025_CR26","doi-asserted-by":"publisher","first-page":"20130715","DOI":"10.1016\/j.ejogrb.2013.06.015","volume":"170","author":"L Qiu","year":"2013","unstructured":"Qiu L, Wang S, Lang JH et al (2013) The occurrence of endometriosis with ovarian carcinomas is not purely coincidental. Eur J Obstet Gynecol Reprod Biol 170(225\u2013228):20130715. https:\/\/doi.org\/10.1016\/j.ejogrb.2013.06.015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1642\u20131650","key":"8025_CR27","doi-asserted-by":"publisher","first-page":"20240304","DOI":"10.1007\/s43032-024-01489-9","volume":"31","author":"F Chiaffarino","year":"2024","unstructured":"Chiaffarino F, Cipriani S, Ricci E et al (2024) Histologic subtypes in endometriosis-associated ovarian cancer and ovarian cancer arising in endometriosis: a systematic review and meta-analysis. Reprod Sci 31(1642\u20131650):20240304. https:\/\/doi.org\/10.1007\/s43032-024-01489-9","journal-title":"Reprod Sci"},{"issue":"70\u201377","key":"8025_CR28","doi-asserted-by":"publisher","first-page":"20230313","DOI":"10.1097\/pgp.0000000000000952","volume":"43","author":"C Wepy","year":"2024","unstructured":"Wepy C, Nucci MR, Parra-Herran C (2024) Atypical endometriosis: comprehensive characterization of clinicopathologic, immunohistochemical, and molecular features. Int J Gynecol Pathol 43(70\u201377):20230313. https:\/\/doi.org\/10.1097\/pgp.0000000000000952","journal-title":"Int J Gynecol Pathol"},{"key":"8025_CR29","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1136\/ijgc-2023-005139","volume":"34","author":"U Leone Roberti Maggiore","year":"2024","unstructured":"Leone Roberti Maggiore U, Bogani G, Paolini B et al (2024) Endometriosis-associated ovarian cancer: a different clinical entity. Int J Gynecol Cancer 34:863\u2013870. https:\/\/doi.org\/10.1136\/ijgc-2023-005139","journal-title":"Int J Gynecol Cancer"},{"key":"8025_CR30","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1200\/jco.2002.20.5.1248","volume":"20","author":"RE Bristow","year":"2002","unstructured":"Bristow RE, Tomacruz RS, Armstrong DK et al (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20:1248\u20131259. https:\/\/doi.org\/10.1200\/jco.2002.20.5.1248","journal-title":"J Clin Oncol"},{"key":"8025_CR31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1046\/j.1365-2559.1997.d01-592.x","volume":"30","author":"M Fukunaga","year":"1997","unstructured":"Fukunaga M, Nomura K, Ishikawa E et al (1997) Ovarian atypical endometriosis: its close association with malignant epithelial tumours. Histopathology 30:249\u2013255. https:\/\/doi.org\/10.1046\/j.1365-2559.1997.d01-592.x","journal-title":"Histopathology"},{"issue":"110","key":"8025_CR32","doi-asserted-by":"publisher","first-page":"20210828","DOI":"10.1186\/s13048-021-00865-2","volume":"14","author":"KA So","year":"2021","unstructured":"So KA, Hong SR, Kim NR et al (2021) Association between atypical endometriosis and ovarian malignancies in the real world. J Ovarian Res 14(110):20210828. https:\/\/doi.org\/10.1186\/s13048-021-00865-2","journal-title":"J Ovarian Res"},{"key":"8025_CR33","first-page":"831","volume":"43","author":"DH Guo","year":"2008","unstructured":"Guo DH (2008) Pang SJ and Shen Y [Atypical endometriosis: a clinicopathologic study of 163 cases]. Zhonghua Fu Chan Ke Za Zhi 43:831\u2013834","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"8025_CR34","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1530\/rep.1.00020","volume":"127","author":"R Varma","year":"2004","unstructured":"Varma R, Rollason T, Gupta JK et al (2004) Endometriosis and the neoplastic process. Reproduction 127:293\u2013304. https:\/\/doi.org\/10.1530\/rep.1.00020","journal-title":"Reproduction"},{"key":"8025_CR35","unstructured":"Board Whocwhocte 2020 Female Genital Tumours. International Agency for Research on Cancer"},{"issue":"69\u201379","key":"8025_CR36","doi-asserted-by":"publisher","first-page":"20200309","DOI":"10.5507\/bp.2020.006","volume":"165","author":"J Lenz","year":"2021","unstructured":"Lenz J, Chvatal R, Fiala L et al (2021) Comparative immunohistochemical study of deep infiltrating endometriosis, lymph-node endometriosis and atypical ovarian endometriosis including description of a perineural invasion. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 165(69\u201379):20200309. https:\/\/doi.org\/10.5507\/bp.2020.006","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"issue":"1532\u20131543","key":"8025_CR37","doi-asserted-by":"publisher","first-page":"20100908","DOI":"10.1056\/NEJMoa1008433","volume":"363","author":"KC Wiegand","year":"2010","unstructured":"Wiegand KC, Shah SP, Al-Agha OM et al (2010) ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med 363(1532\u20131543):20100908. https:\/\/doi.org\/10.1056\/NEJMoa1008433","journal-title":"N Engl J Med"},{"issue":"114909","key":"8025_CR38","doi-asserted-by":"publisher","first-page":"20230519","DOI":"10.1016\/j.biopha.2023.114909","volume":"164","author":"M Zhang","year":"2023","unstructured":"Zhang M, Xu T, Tong D et al (2023) Research advances in endometriosis-related signaling pathways: a review. Biomed Pharmacother 164(114909):20230519. https:\/\/doi.org\/10.1016\/j.biopha.2023.114909","journal-title":"Biomed Pharmacother"},{"issue":"383\u2013391","key":"8025_CR39","doi-asserted-by":"publisher","first-page":"20091025","DOI":"10.1007\/s10147-009-0935-y","volume":"14","author":"M Mandai","year":"2009","unstructured":"Mandai M, Yamaguchi K, Matsumura N et al (2009) Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management. Int J Clin Oncol 14(383\u2013391):20091025. https:\/\/doi.org\/10.1007\/s10147-009-0935-y","journal-title":"Int J Clin Oncol"},{"key":"8025_CR40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/biolre\/ioab054","volume":"105","author":"A AlAshqar","year":"2021","unstructured":"AlAshqar A, Reschke L, Kirschen GW et al (2021) Role of inflammation in benign gynecologic disorders: from pathogenesis to novel therapies\u2020. Biol Reprod 105:7\u201331. https:\/\/doi.org\/10.1093\/biolre\/ioab054","journal-title":"Biol Reprod"},{"issue":"449","key":"8025_CR41","doi-asserted-by":"publisher","first-page":"20220423","DOI":"10.1186\/s12885-022-09588-z","volume":"22","author":"S Ye","year":"2022","unstructured":"Ye S, Zhou S, Zhong S et al (2022) The frequency and clinical implication of mismatch repair protein deficiency in Chinese patients with ovarian clear cell carcinoma. BMC Cancer 22(449):20220423. https:\/\/doi.org\/10.1186\/s12885-022-09588-z","journal-title":"BMC Cancer"},{"issue":"741\u2013750","key":"8025_CR42","doi-asserted-by":"publisher","first-page":"20210708","DOI":"10.1016\/j.ygyno.2021.06.033","volume":"162","author":"A Gadducci","year":"2021","unstructured":"Gadducci A, Multinu F, Cosio S et al (2021) Clear cell carcinoma of the ovary: epidemiology, pathological and biological features, treatment options and clinical outcomes. Gynecol Oncol 162(741\u2013750):20210708. https:\/\/doi.org\/10.1016\/j.ygyno.2021.06.033","journal-title":"Gynecol Oncol"},{"issue":"615\u2013624","key":"8025_CR43","doi-asserted-by":"publisher","first-page":"20111209","DOI":"10.1038\/modpathol.2011.189","volume":"25","author":"S Yamamoto","year":"2012","unstructured":"Yamamoto S, Tsuda H, Takano M et al (2012) Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations. Mod Pathol 25(615\u2013624):20111209. https:\/\/doi.org\/10.1038\/modpathol.2011.189","journal-title":"Mod Pathol"},{"issue":"1831\u20131842","key":"8025_CR44","doi-asserted-by":"publisher","first-page":"20150606","DOI":"10.1016\/j.ejca.2015.05.011","volume":"51","author":"MJ Worley Jr","year":"2015","unstructured":"Worley MJ Jr, Liu S, Hua Y et al (2015) Molecular changes in endometriosis-associated ovarian clear cell carcinoma. Eur J Cancer 51(1831\u20131842):20150606. https:\/\/doi.org\/10.1016\/j.ejca.2015.05.011","journal-title":"Eur J Cancer"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-025-08025-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-025-08025-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-025-08025-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T06:12:01Z","timestamp":1750227121000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-025-08025-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["8025"],"URL":"https:\/\/doi.org\/10.1007\/s00404-025-08025-3","relation":{},"ISSN":["1432-0711"],"issn-type":[{"type":"electronic","value":"1432-0711"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"assertion":[{"value":"4 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Since the retrospective study utilized anonymous patient information, the Research Ethics Committee of West China Second Hospital, Sichuan University, confirmed that no ethical approval was required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}